Private patient perceptions about a public programme; what do private Indian tuberculosis patients really feel about directly observed treatment?
Lancelot M Pinto, Zarir F Udwadia, Lancelot M Pinto, Zarir F Udwadia
Abstract
Background: India accounts for one-fifth of the global incident cases of tuberculosis(TB). The country presently has the world's largest directly observed treatment, short course (DOTS) programme, that has shown impressive results and covers almost 100% of the billion-plus Indian population. Despite such a successful programme, the majority of Indian patients with tuberculosis prefer private healthcare, although repeated audits of this sector have shown the quality to be poor. We aimed to ascertain the level of awareness and knowledge of private patients with tuberculosis attending our clinic at a tertiary private healthcare institute with regards to the DOTS programme, understanding the reasons behind their preference for private healthcare, and evaluating their perceptions and reasons for accepting or failing to accept directly observed therapy as a treatment option.
Methods: A structured interview schedule was administered to private patients with tuberculosis at the P.D. Hinduja Hospital and Medical Research Centre, Mumbai, India between January 2006 to November 2007.
Results: Only 30 of 200 patients (15%) were aware of the DOTS programme. After being explained what directly observed therapy was, 136 patients (68%) found this form of treatment unacceptable.183 patients (91.5%) preferred buying the drugs themselves to visiting a DOTS centre. 90 patients (45%) were not prepared to be observed while swallowing their TB drugs, finding it an intrusion of privacy.
Conclusions: Our study reveals a poor knowledge and awareness of the DOTS programme among the cohort of TB patients that we interviewed. The control of TB in India will undoubtedly benefit from more patients being attracted to and treated by the existing DOTS programmes. However, directly observed treatment, in its present form, is considered too rigid and intrusive and is unlikely to be accepted by a majority of patients seeking private healthcare. Novel strategies and more flexible options will have to be devised to ensure higher cure rates without compromising patient choice.
References
- Mathers CD, Boerma T, Ma Fat D. Global and regional causes of death. Br Med Bull. 2009;92:7–32. doi: 10.1093/bmb/ldp028.
- Global tuberculosis control: surveillance, planning, financing. WHO report. 2007. World Health Organization WHO/HTM/TB/2007376.
- Chadha VK. Annual risk of tuberculous infection in four defined zones of India: a comparative picture. Int J Tuberc Lung Dis. 2005;9(5):569–75.
- Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India 2009. TB India 2009. RNTCP Status report. Accessed 1 February 2010.
- Uplekar M, Pathania V, Raviglione M. Private practitioners and public health: weak links in tuberculosis control. Lancet. 2001;358(9285):912–6. doi: 10.1016/S0140-6736(01)06076-7.
- Uplekar M, Rangan S. Tackling TB: the search for solutions. Bombay: The Foundation for Research in Community Health; 1996.
- Uplekar MW, Shepard DS. Treatment of tuberculosis by private general practitioners in India. Tubercle. 1991;72(4):284–90. doi: 10.1016/0041-3879(91)90055-W.
- Uplekar M. Tuberculosis patients and practitioners in private clinics in India. Int J Tuberc Lung Dis. 1998;2(4):324–9.
- Arora VK. Panel discussion on MDR and XDR TB. Moderated by Dr. V.K. Arora. Indian J Tuberc. 2008;55(2):104–9.
- Suganthi P. Health seeking and knowledge about tuberculosis among persons with pulmonary symptoms and tuberculosis cases in Bangalore slums. Int J Tuberc Lung Dis. 2008;12(11):1268–73.
- Udwadia Z. Specific problems of tuberculosis control in India. 3. Oxford University Press;
- World Health Organization. Anti-tuberculosis drug resistance in the world - Fourth Global Report. WHO/HTM/TB/2008.394. 2008.
- D'Souza DT. High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India. Vol. 9. BMC Public Health; 2009. p. 211.
- Udwadia Z, Pinto L, Uplekar M. Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades? in press .
- Sharma N. The impact of an IEC campaign on tuberculosis awareness and health seeking behaviour in Delhi, India. Int J Tuberc Lung Dis. 2005;9(11):1259–65.
- Dewan PK. Improving tuberculosis control through public-private collaboration in India: literature review. BMJ. 2006;332(7541):574–8. doi: 10.1136/bmj.38738.473252.7C.
- Pantoja A. Economic evaluation of public-private mix for tuberculosis care and control, India. Part II. Cost and cost-effectiveness. Int J Tuberc Lung Dis. 2009;13(6):705–12.
- Sudha G. Factors influencing the care-seeking behaviour of chest symptomatics: a community-based study involving rural and urban population in Tamil Nadu, South India. Trop Med Int Health. 2003;8(4):p. 336–41. doi: 10.1046/j.1365-3156.2003.01010.x.
- Jaiswal A. Adherence to tuberculosis treatment: lessons from the urban setting of Delhi, India. Trop Med Int Health. 2003;8(7):625–33. doi: 10.1046/j.1365-3156.2003.01061.x.
- Newell JN. Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial. Lancet. 2006;367(9514):903–9. doi: 10.1016/S0140-6736(06)68380-3.
- Lonnroth K. Can I afford free treatment?: Perceived consequences of health care provider choices among people with tuberculosis in Ho Chi Minh City, Vietnam. Soc Sci Med. 2001;52(6):935–48. doi: 10.1016/S0277-9536(00)00195-7.
- Social Assessment Study for RNTCP - Final Report, Submitted to: Central TB Division, Ministry of Health and Family Welfare (Government of India), New Delhi. ORG Centre for Social Research. 2003.
- Marinker M, Shaw J. Not to be taken as directed. BMJ. 2003;326(7385):348–9. doi: 10.1136/bmj.326.7385.348.
Source: PubMed